Breaking News Instant updates and real-time market news.

LB

L Brands

$35.28

-0.41 (-1.15%)

, JCP

J.C. Penney

$1.29

-0.08 (-5.84%)

12:34
11/17/18
11/17
12:34
11/17/18
12:34

Kohl's, Target set to thrive this holiday season, Barron's says

Store chains have been learning lessons from Amazon's (AMZN) success and investing in e-commerce fulfillment, and for stores that struggle now, the problem is them, not the economy or Amazon, Jack Hough writes in this week's edition of Barron's. To find likely winners, stock investors should be cautious of malls, and of stores with a shortage of unique merchandise, while being bullish on those with digital savvy, the publication notes. Kohl's (KSS) and Target (TGT) appear poised to outperform, and Home Depot (HD) and Tiffany (TIF) are worth their premium valuations, while Best Buy (BBY) has had a heroic run, but now faces especially difficult sales comparisons versus last year, Hough contends. TJX (TJX) could cool, too and the outlook is not promising for J.C. Penney (JCP) and L Brands (LB), he adds. Reference Link

LB

L Brands

$35.28

-0.41 (-1.15%)

JCP

J.C. Penney

$1.29

-0.08 (-5.84%)

TJX

TJX

$51.47

-0.98 (-1.87%)

BBY

Best Buy

$66.41

-1.34 (-1.98%)

TIF

Tiffany

$106.48

0.52 (0.49%)

HD

Home Depot

$177.11

-0.25 (-0.14%)

TGT

Target

$79.67

-1.09 (-1.35%)

KSS

Kohl's

$72.48

-0.7 (-0.96%)

AMZN

Amazon.com

$1,593.59

-26.41 (-1.63%)

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 28

    Nov

  • 04

    Dec

  • 05

    Dec

  • 03

    Mar

LB L Brands
$35.28

-0.41 (-1.15%)

11/12/18
11/12/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Starbucks (SBUX) upgraded to Buy from Hold at Argus with analyst John Staszak citing his expectations of "continued revenue growth and new store openings" for the company, forecasting 14% EPS growth and 15% in total returns over the next several years. 2. L Brands (LB) upgraded to Outperform from Market Perform at Wells Fargo with analyst Ike Boruchow saying while he is not calling for an imminent inflection in the business, he now sees L Brands as the next retail turnaround story poised for positive shift in the "narrative" as the company appears set to begin embracing change with an "all options on the table" mentality. 3. Armstrong World (AWI) upgraded to Neutral from Underperform at BofA/Merrill with analyst John Lovallo saying Armstrong World deserves a higher multiple following the spin-off of Armstrong Flooring in April 2016 and is positive on the company's capital deployment strategy including buybacks, a recently initiated dividend, and tuck-in M&A. 4. Michael Kors (KORS) upgraded to Market Perform from Underperform at Bernstein with analyst Jamie Merriman citing valuation. 5. Crocs (CROX) upgraded to Neutral from Negative at Susquehanna. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/12/18
11/12/18
UPGRADE
Target $55

Outperform
L Brands upgraded to Outperform on 2019 turnaround story at Wells Fargo
As previously reported, Wells Fargo analyst Ike Boruchow upgraded L Brands to Outperform from Market Perform and raised his price target for the shares to $55 from $30 on compelling 2019 turnaround story. While the analyst is not calling for an imminent inflection in the business, he now sees L Brands as the next retail turnaround story poised for positive shift in the "narrative" as the company appears set to begin embracing change with an "all options on the table" mentality. Specifically, the recent announcements to divest the money losing Bendel business illustrates a new focus on the portfolio, he contends. Moreover, Boruchow sees a meaningful opportunity for a re-rating in shares.
11/12/18
WELS
11/12/18
UPGRADE
WELS
Outperform
L Brands upgraded to Outperform from Market Perform at Wells Fargo
11/09/18
MKMP
11/09/18
NO CHANGE
Target $34
MKMP
Neutral
L Brands price target raised to $34 from $31 at MKM Partners
MKM Partners analyst Roxanne Meyer raised her price target on L Brands to $34 after its October comps and Q3 earnings guidance. The analyst notes that the visibility around its Victoria's Secret brand remains low, but also considers whether the segment's variability is lower than she initially estimated. Meyer keeps her Neutral rating but raises her FY18 EPS view to $2.69 from $2.61, forecasting continued strength in L Brands' Bath & Both Works business.
JCP J.C. Penney
$1.29

-0.08 (-5.84%)

11/16/18
11/16/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Home Depot (HD) downgraded to Neutral from Buy at BofA/Merrill with analyst Elizabeth Suzuki saying peak growth has passed. 2. J.C. Penney (JCP) downgraded to Sell from Hold at Argus with analyst John Eade saying he anticipates continued losses for the stock for the next two years while also warning that at a current share price below $2, the company is operating with a more elevated risk. 3. Nvidia (NVDA) was downgraded to Neutral from Buy at B. Riley FBR and to Buy from Conviction Buy at Goldman Sachs. 4. Michael Kors (KORS) downgraded to Perform from Outperform at Oppenheimer with analyst Brian Nagel saying he is "concerned" that ongoing challenges with inventory management and replenishment at the company's namesake brand and softness within fashion watches will weigh on top-line trends and potentially margins, just as management begins the integration of Versace. 5. TSMC (TSM) was downgraded to Equal Weight from Overweight at Morgan Stanley while UMC (UMC) was downgraded to Underweight from Equal Weight. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/16/18
ARGS
11/16/18
DOWNGRADE
ARGS
Sell
J.C. Penney downgraded to Sell from Hold at Argus
Argus analyst John Eade downgraded J.C. Penney to Sell, anticipating continued losses for the stock for the next two years while also warning that at a current share price below $2, the company is operating with a more elevated risk. The analyst states that while J.C Penney has made efforts to "restructure its merchandise assortment, close underperforming stores, and bolster its Omnichannel business, its operating results continue to deteriorate." Eade cites the company's margin deterioration coming from store closings, poor inventory management, and "steep discounting" intended to clear excess inventory. The analyst also sees J.C. Penney operating against "intense" competition from a wide range of retailers and suffering from weak mall traffic, while also facing a very expensive "arms race" to improve e-commerce capabilities.
11/16/18
ARGS
11/16/18
DOWNGRADE
ARGS
Sell
J.C. Penney downgraded to Sell from Hold at Argus
10/12/18
MSCO
10/12/18
NO CHANGE
Target $1.5
MSCO
Equal Weight
Morgan Stanley sees near-term pressure, long-term gain for Penney if Sears folds
Amid recent headlines regarding Sears (SHLD) adding a restructuring expert and reportedly pursuing a bankruptcy filing, Morgan Stanley analyst Kimberly Greenberger noted that she believes J.C. Penney (JCP) had the highest store overlap with Sears, K-Mart, and Sears Specialty Stores within both a quarter mile and half mile radius. If Sears closes additional stores or engages in liquidation sales, retailers in the close trade areas could experience some short-term pressure, said Greenberger, who added that Sears has already been closing stores for years. In the medium to long-term, she expects J.C. Penney and other retailers in the respective trade areas to potentially benefit from these closures. Greenberger, who views Penney's near-term debt maturities as "manageable," keeps an Equal Weight rating and $1.50 price target on the shares.
TJX TJX
$51.47

-0.98 (-1.87%)

09/11/18
LEHM
09/11/18
INITIATION
Target $117
LEHM
Equal Weight
TJX initiated with an Equal Weight at Barclays
Barclays analyst Chethan Mallela started TJX with an Equal Weight rating and $117 price target. The company has a "solid revenue growth runway," but the magnitude of earnings flow-through is less clear, Mallela tells investors in a research note. The analyst needs better visibility to margin stabilization and expansion before getting more constructive on the shares.
09/11/18
LEHM
09/11/18
INITIATION
Target $194
LEHM
Overweight
Barclays views Burlington Stores as differentiated, starts with Overweight
Barclays analyst Chethan Mallela initiated coverage of Burlington Stores (BURL) with an Overweight rating and $194 price target. He also started both Ross Stores (ROST) and TJX (TJX) with Equal Weight ratings. Burlington is differentiated in the off-price subsector given its "less productive and established" store footprint, and significantly lower operating margins versus the peer group, Mallela tells investors in a research note. As Burlington "continues to address these disparities," the analyst expects faster and more visible top- and bottom-line growth.
09/25/18
DADA
09/25/18
INITIATION
Target $130
DADA
Buy
TJX initiated with a Buy at DA Davidson
DA Davidson analyst John Morris initiated TJX with a Buy rating and a price target of $130, saying the company's leading position in the off-price sector allows it to take market share amid the secular decline of department and chain stores. The analyst expects the company to produce a strong set of results in the second half of the year thanks to rising average unit retail momentum as well as upturn in women's apparel. Morris contends that the premium multiple of TJX is warranted by its off-price "leadership, size advantages, global diversification, and strong financial position".
09/25/18
DADA
09/25/18
INITIATION
Target $96
DADA
Neutral
Ross Stores initiated with a Neutral at DA Davidson
DA Davidson analyst John Morris initiated Ross Stores (ROST) with a Neutral rating and a price target of $96. The analyst says its current valuation is at the upper end of its historical earnings multiple range and also a 10% premium over that of the off-price leader TJX (TJX). Morris adds that given his "low visibility" over the company's "degree of success in penetrating new competitive markets", he is "hard-pressed to argue for further multiple expansion".
BBY Best Buy
$66.41

-1.34 (-1.98%)

11/13/18
BOFA
11/13/18
DOWNGRADE
Target $70
BOFA
Neutral
Best Buy downgraded to Neutral from Buy at BofA/Merrill
BofA/Merrill analyst Curtis Nagle downgraded Best Buy to Neutral from Buy and cut its price target to $70 from $92 due to expectations for slowing industry growth, difficult comps in key products and cost inflation. Nagle believes Best Buy can grow earnings over the next few years, but at a slower rate and does not believe a premium multiple is warranted.
11/13/18
11/13/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Lumentum (LITE) downgraded to Neutral from Overweight at JPMorgan with analyst Samik Chatterjee saying yesterday's negative pronouncement underscored the challenges likely to be faced by Apple (AAPL) supply chain companies in delivering to investor expectations as Apple continues to prioritize its premium pricing strategy on iPhones relative to volumes. 2. Best Buy (BBY) downgraded to Neutral from Buy at BofA/Merrill with analyst Curtis Nagle citing expectations for slowing industry growth, difficult comps in key products and cost inflation. 3. Perrigo (PRGO) downgraded to Hold from Buy at Berenberg with analyst Patrick Trucchio saying although the key reason to own Perrigo shares remains intact, namely the U.S. government's push to shift more products from prescription to nonprescription, "too much uncertainty in generics has placed us on the sidelines." 4. Sabra Health Care (SBRA) downgraded to Neutral from Buy at Mizuho with analyst Richard Anderson saying he wants to a take a "pause" until the earnings reset from the "surprise news" of Senior Care stopping rent payments since May becomes better understood. 5. Infinera (INFN) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Meta Marshall saying she sees "no reason to race in" until there are signs that the revenue base has stabilized. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/12/18
LOOP
11/12/18
NO CHANGE
Target $88
LOOP
Buy
Best Buy sell-off on Amazon's Apple distribution overdone, says Loop Capital
Loop Capital analyst Anthony Chukumba kept his Buy rating and $88 price target on Best Buy (BBY), calling the 7.4% drop in its stock price on Friday "overdone". The analyst points to the news of Amazon (AMZN) starting to offer a much wider variety of Apple (AAPL) products, but believes that the impact on Best Buy is unlikely to be material. Chukumba cites Amazon's plans to sell products at the same "Apple-mandated prices as Best Buy", adding that a fair amount of Amazon's sales of Apple products will "cannibalize Apple unauthorized sales that were previously taking place on its website".
11/12/18
BERN
11/12/18
NO CHANGE
BERN
Best Buy status as 'last man standing' not enough to support valuation, says Bernstein
Bernstein analyst Brandon Fletcher notes that news reports suggest that Amazon (AMZN) has made a deal for a larger and more first-party controlled top-tier brand assortments. The analyst suspects Amazon may be in line for a higher allocation on new products if the relationships deepen with top vendors. Best Buy (BBY) has lived on very large allocations of new products because some customers need some help in stores and some product makers need some help in promotion of new releases, he contends. With smartphone launches covered intensely by social media networks and traditional media, it was never clear to Fletcher how long that Best Buy would defend the promotional aspect, leaving it playing only a shrinking role of support for a subset of customers who still want some traditional retail Service. However, the analyst believes that group is aging out and Best Buy's protected status as the "last man standing" in electronics may not be enough to support the high valuations.
TIF Tiffany
$106.48

0.52 (0.49%)

10/12/18
OPCO
10/12/18
NO CHANGE
Target $152
OPCO
Outperform
Tiffany's underlying fundamentals, recovery 'intact,' says Oppenheimer
Oppenheimer analyst Brian Nagel reiterated an Outperform rating and $152 price target on Tiffany & Co. Nagel tells investors in a research note that he believes the underlying fundamentals and recovery at Tiffany remain intact, but that there may be credence to recent market concerns of the Chinese government regulating the flow of foreign purchased products into the country. He expects internal disciplines and drivers to continue to take hold with a brand that will prove increasingly well positioned.
09/26/18
COWN
09/26/18
NO CHANGE
Target $150
COWN
Outperform
Tiffany estimates raised on growth prospects at Cowen
Cowen analyst Oliver Chen raised his estimates on Tiffany to reflect his conviction in the company's growth prospects from improved product, marketing, and customer engagement. He also sees margins expansion from favorable commodity cost trends and global expansion strength in lower price point products. Chen reiterated his Outperform rating and $150 price target on Tiffany shares.
09/12/18
09/12/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. TerraForm Power (TERP) upgraded to Neutral from Sell at Goldman Sachs with analyst Brian Lee saying the recent underperformance of the shares has driven a more balanced risk/reward profile. 2. Tiffany (TIF) upgraded to Outperform from Perform at Oppenheimer with analyst Brian Nagel stating he believes the risk/reward trade-off in owning the stock nearer term is now much more favorable. 3. Best Inc. (BSTI) upgraded to Outperform from Neutral at Macquarie with analyst Eric Zong saying he believes Best's current valuation reflects the value of the express delivery business, approximately $6.53/share, but ignores the remaining business. 4. Immersion (IMMR) upgraded to Buy from Hold at Craig-Hallum with analyst Anthony Stoss stating he believes the stock is now back into favorable risk/reward waters. 5. DexCom (DXCM) upgraded to Market Perform from Underperform at Northland with analyst Suraj Kalia saying he was "dead wrong" on the stock and G6 should continue to grow. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/15/18
KEYB
10/15/18
NO CHANGE
Target $150
KEYB
Overweight
KeyBanc bullish on Tiffany as CEO takes 'bold moves' to accelerate business
KeyBanc analyst Edward Yruma says he is not dismissive of near-term dynamics and would be opportunistic on volatility as the company's new CEO is taking "bold moves" to accelerate the business. China remains a significant long-term growth opportunity, while commodities are a favorable near-term tailwind. Yruma reiterates an Overweight rating and $150 price target on the shares.
HD Home Depot
$177.11

-0.25 (-0.14%)

11/14/18
SBSH
11/14/18
NO CHANGE
Target $226
SBSH
Buy
Home Depot weakness on housing concerns a buying opportunity, says Citi
Citi analyst Kate McShane attributes the post-earnings weakness yesterday in shares of Home Depot to ongoing concern over the U.S. housing market and the prospects for growth in home improvement spend over the next year. While housing trends have been mixed in recent months, Home Depot management's outlook remains constructive, McShane tells investors in a research note. She sees a buying opportunity in the shares following the weakness yesterday and reiterates a Buy rating on the name. The analyst trimmed her price target for the shares to $226 from $227.
11/14/18
STFL
11/14/18
NO CHANGE
Target $200
STFL
Buy
Home Depot price target lowered to $200 from $225 at Stifel
Stifel analyst John Baugh said Home Depot reported a number of positive trends in Q3 and while he is less concerned over Q4 guidance, noting that the company tends to "under promise and over deliver," he does see it as prudent to modestly lower his comparable sales growth assumptions for 2019 to reflect the lower lumber prices, foreign exchange headwinds and expectations for housing price growth to modestly slow. He lowered his price target on Home Depot to $200 from $225, but keeps a Buy rating on the name.
11/16/18
BOFA
11/16/18
DOWNGRADE
Target $195
BOFA
Neutral
Home Depot downgraded to Neutral from Buy at BofA/Merrill
BofA/Merrill analyst Elizabeth Suzuki downgraded Home Depot to Neutral from Buy and reduced her price target to $195 from $219 saying peak growth has passed. Suzuki believes 2018 was a peak earnings growth year and 2017 was a likely peak in comps, coinciding with a peak in house sales. The analyst expects home improvement conditions to soften in 2H 2019 and for earnings beats to get smaller, keeping investors on the sidelines.
TGT Target
$79.67

-1.09 (-1.35%)

11/16/18
11/16/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Adobe (ADBE) initiated with a Buy at Nomura Instinet. 2. Target (TGT) was initiated with a Buy at Buckingham and an Overweight at KeyBanc. 3. Viad (VVI) initiated with a Buy at Janney Montgomery Scott. 4. Selective Insurance (SIGI) initiated with a Market Perform at JMP Securities. 5. Sprouts Farmers Market (SFM) initiated with an Underperform at Bernstein. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/16/18
KEYB
11/16/18
INITIATION
Target $110
KEYB
Overweight
Target initiated with an Overweight at KeyBanc
KeyBanc analyst Edward Yruma initiated Target (TGT) with an Overweight rating and $110 price target. The analyst says Target's investments and improved execution are driving stronger comps, telling investors in a research note that he thinks this is sustainable in the current environment. Rather than viewing Target as a participant in the Amazon (AMZN) vs. Walmart (WMT) battle, Yruma thinks its unique mix of consumables and high-margin apparel/home decor leave it well-positioned to take share from at-risk retailers.
11/15/18
BUCK
11/15/18
INITIATION
BUCK
Buy
Target initiated with a Buy at Buckingham
Buckingham analyst Bob Summers initiated Target with a Buy rating and $102 price target. The analyst expects comparable store sales strength to continue at least for the next few quarters, seeing 4.5% in Q3 and Q4, conservatively. Summers also sees Target benefitting from strong holiday spending and the recent bankruptcy at Toys-R-Us.
11/15/18
BUCK
11/15/18
INITIATION
Target $102
BUCK
Buy
Target initiated with a Buy at Buckingham
Buckingham initiated Target with a Buy and $102 price target.
KSS Kohl's
$72.48

-0.7 (-0.96%)

09/03/18
GSCO
09/03/18
INITIATION
Target $91
GSCO
Buy
Kohl's initiated with a Buy at Goldman Sachs
Goldman Sachs started Kohl's with a Buy rating and $91 price target. The firm initiated the Apparel & Accessories space with an Attractive view on department stores and off-price retailers.
09/04/18
GSCO
09/04/18
INITIATION
Target $73
GSCO
Conviction Buy
Goldman starts Nordstrom with Conviction Buy, Macy's with Sell
Goldman Sachs analyst Alexandra Walvis initiated coverage of the Apparel & Accessories Retail sector with an Attractive coverage view. The analyst sees an "ongoing role for select best-in-class brick and mortar retailers" and feels "underappreciated business models" offer upside in select stocks. Walvis initiated coverage of Nordstrom (JWN) with a Buy rating and $73 price target and added the shares to her firm's Conviction List. The company offers a "full price business with a strong omnichannel offer and premium curated product," the analyst tells investors in a research note. On the other side, Walvis started Macy's (M) with a Sell rating and $33 price target. The company's strategic initiatives are insufficient to offset traffic headwinds for its portfolio of large, mall-based stores, Walvis contends. The analyst also put Buy ratings on Kohl's (KSS) and TJX (TJX), and Neutral ratings on Burlington Stores (BURL) and Ross Stores (ROST).
10/10/18
BARD
10/10/18
NO CHANGE
Target $90
BARD
Outperform
Kohl's recent weakness improves risk/reward, says Baird
Baird analyst Mark Altschwager noted Kohl's unveiled its new pilot store, which he said illustrates how the company continues to invest in both the online and brick & mortar experience to refine a best-in-class omnichannel model. Altschwager, who said the recent selloff over the past month has improved the risk/reward, reiterated his Outperform rating and $90 price target on Kohl's shares.
11/02/18
OTRG
11/02/18
UPGRADE
OTRG
Positive
Kohl's upgraded to Positive from Mixed at OTR Global
AMZN Amazon.com
$1,593.59

-26.41 (-1.63%)

11/16/18
MKMP
11/16/18
NO CHANGE
Target $415
MKMP
Buy
Netflix, Amazon price targets raised at MKM Partners
MKM Partners analyst Rob Sanderson raised his price targets on Buy rated Netflix (NFLX) and Amazon (AMZN) to $415 from $395 and $2,240 from $2,215 respectively as part of his broader research note titled "Victims of Risk-off Environment; Recommend Buying Weakness". The analyst states that these stocks have been among the weaker performers in the underperforming Internet sector, but should become "excellent performers" over the next 12 months if his view attributing the recent correction in the broader market to a late-cycle pause amidst geo-political uncertainty and Fed concerns proves to be correct. As part of this research note, Sanderson also keeps his Buy rating on Spotify (SPOT) but lowers its price target to $200 from $245, applying a 25-times forward earnings multiple in rolling out his valuation to 2022, with added currency related pressure against the "much less contentious" expected renewal rates in 2019.
11/15/18
PIPR
11/15/18
NO CHANGE
Target $2050
PIPR
Overweight
Amazon shares offer 'opportunity for material appreciation,' says Piper Jaffray
The downdraft in technology names has driven valuations to "opportunistic levels for certain stocks," Piper Jaffray analyst Michael Olson tells investors in a research note partially titled "Champagne Stock on a Beer Budget." In particular, Amazon "presents an opportunity for material appreciation in the coming 12-24 months," says the analyst. His analysis of Amazon's valuation suggests the company's core retail business is trading in-line with low single digit growth brick and mortar retailers. While some investors were disappointed with Amazon's revenue growth deceleration in Q3, Olson says he's encouraged by potential for ongoing margin expansion and bottom line upside. Amazon has beaten Q4 operating income guidance by an average of 94% in the past three years, suggesting that a typical beat would exceed where consensus Q4 expectations were going into the Q3 report, says the analyst. He reiterates an Overweight rating on the shares with a $2,050 price target. Amazon closed yesterday down 2%, or $32.16, to $1,599.01.
11/14/18
EVER
11/14/18
NO CHANGE
Target $1990
EVER
Outperform
Amazon's AWS operating income estimates likely conservative, says Evercore ISI
Evercore ISI analyst Anthony DiClemente kept his Outperform rating and $1,990 price target on Amazon.com, saying his deeper analysis of the company's AWS business earnings power over the longer term suggests that the consensus is "likely too conservative". The analyst states that his "dynamic model" indicates a pathway of 35% or greater operating margins by 2022 under "bullish, but still undemanding assumptions." DiClemente adds that the Street is giving Amazon "little credit for ongoing efficiency gains", only calling for about 100bps in operating margin expansion between 2018 and 2021.

TODAY'S FREE FLY STORIES

JELD

Jeld-Wen

$14.27

-0.46 (-3.12%)

13:02
12/16/18
12/16
13:02
12/16/18
13:02
Hot Stocks
Jeld-Wen announces final ruling in Steves & Sons litigation, to appeal decision »

Jeld-Wen announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATRA

Atara Biotherapeutics

$41.78

-0.74 (-1.74%)

12:55
12/16/18
12/16
12:55
12/16/18
12:55
Hot Stocks
Atara Biotherapeutics presents positive efficacy, safety results for EBV + LMS »

Atara Biotherapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BGNE

BeiGene

$133.95

2.595 (1.98%)

12:41
12/16/18
12/16
12:41
12/16/18
12:41
Hot Stocks
BeiGene announces updated Phase 1A/1B data on tislelizumab »

BeiGene announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JELD

Jeld-Wen

$14.27

-0.46 (-3.12%)

12:35
12/16/18
12/16
12:35
12/16/18
12:35
Hot Stocks
Jeld-Wen ordered to divest Pennsylvania plant to restore competition »

Federal Judge Robert…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$52.11

-1.54 (-2.87%)

, RHHBY

Roche

$0.00

(0.00%)

04:55
12/16/18
12/16
04:55
12/16/18
04:55
Conference/Events
European Society for Medical Oncology (ESMO) to hold a conference »

ESMO Immuno-Oncology…

BMY

Bristol-Myers

$52.11

-1.54 (-2.87%)

RHHBY

Roche

$0.00

(0.00%)

CELG

Celgene

$68.20

-1.55 (-2.22%)

MRK

Merck

$76.50

-1.94 (-2.47%)

PFE

Pfizer

$43.84

-0.71 (-1.59%)

FLDM

Fluidigm

$7.79

-0.39 (-4.77%)

NEO

NeoGenomics

$13.25

-0.18 (-1.34%)

SGEN

Seattle Genetics

$60.46

-0.5 (-0.82%)

TKPYY

Takeda Pharmaceutical

$0.00

(0.00%)

IMV

IMV Inc

$5.65

-0.14 (-2.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 24

    Dec

  • 29

    Dec

  • 11

    Jan

  • 11

    Jan

  • 24

    Jan

  • 16

    Feb

  • 18

    Mar

  • 20

    May

SIR

Select Income REIT

$17.72

-0.52 (-2.85%)

, GOV

Government Properties

$7.68

-0.41 (-5.07%)

17:08
12/15/18
12/15
17:08
12/15/18
17:08
Conference/Events
Select Income REIT to host special shareholder meeting »

Special Shareholder…

SIR

Select Income REIT

$17.72

-0.52 (-2.85%)

GOV

Government Properties

$7.68

-0.41 (-5.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Dec

GOV

Government Properties

$7.68

-0.41 (-5.07%)

, SIR

Select Income REIT

$17.72

-0.52 (-2.85%)

17:06
12/15/18
12/15
17:06
12/15/18
17:06
Conference/Events
Government Properties to host special shareholder meeting »

Special Shareholder…

GOV

Government Properties

$7.68

-0.41 (-5.07%)

SIR

Select Income REIT

$17.72

-0.52 (-2.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$260.61

-4.8 (-1.81%)

12:37
12/15/18
12/15
12:37
12/15/18
12:37
Periodicals
U.S. stocks could rally about 10% in 2019, Barron's says »

As U.S. stocks stumble…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$260.61

-4.8 (-1.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOL

Toll Brothers

$32.23

-0.4 (-1.23%)

, ET

Energy Transfer LP

$14.08

-0.5 (-3.43%)

12:21
12/15/18
12/15
12:21
12/15/18
12:21
Periodicals
Alphabet, Apple among top stock picks for 2019, Barron's says »

Even if investors have…

TOL

Toll Brothers

$32.23

-0.4 (-1.23%)

ET

Energy Transfer LP

$14.08

-0.5 (-3.43%)

DAL

Delta Air Lines

$53.50

-0.03 (-0.06%)

DDAIF

Daimler AG

$0.00

(0.00%)

CVX

Chevron

$113.84

-2.15 (-1.85%)

CAT

Caterpillar

$126.78

0.79 (0.63%)

BLK

BlackRock

$382.25

-5.29 (-1.37%)

BAC

Bank of America

$24.49

0.1 (0.41%)

AAPL

Apple

$165.48

-5.45 (-3.19%)

GOOGL

Alphabet Class A

$1,050.62

-23.36 (-2.18%)

GOOG

Alphabet

$1,041.68

-21.44 (-2.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

  • 12

    Feb

  • 03

    Mar

DDAIF

Daimler AG

$0.00

(0.00%)

, FCAU

Fiat Chrysler

$15.47

-0.2 (-1.28%)

08:26
12/15/18
12/15
08:26
12/15/18
08:26
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

DDAIF

Daimler AG

$0.00

(0.00%)

FCAU

Fiat Chrysler

$15.47

-0.2 (-1.28%)

F

Ford

$8.53

0.025 (0.29%)

GM

General Motors

$35.10

-0.01 (-0.03%)

HMC

Honda

$26.90

-0.33 (-1.21%)

NSANY

Nissan

$0.00

(0.00%)

TM

Toyota

$120.06

-0.83 (-0.69%)

VLKAY

Volkswagen

$0.00

(0.00%)

TSLA

Tesla

$365.69

-11.17 (-2.96%)

LITE

Lumentum

$43.46

-0.4 (-0.91%)

OCLR

Oclaro

$8.27

(0.00%)

FNSR

Finisar

$21.74

-0.4 (-1.81%)

ZTCOY

ZTE Corp.

$0.00

(0.00%)

INFN

Infinera

$4.14

-0.095 (-2.25%)

CIEN

Ciena

$34.55

-0.35 (-1.00%)

GOOS

Canada Goose

$52.18

-2.48 (-4.54%)

FDX

FedEx

$184.08

-3.13 (-1.67%)

UPS

UPS

$98.67

-2.1 (-2.08%)

AMZN

Amazon.com

$1,592.14

-67.86 (-4.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 19

    Dec

  • 20

    Dec

  • 07

    Jan

  • 23

    Jan

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

BMY

Bristol-Myers

$52.11

-1.54 (-2.87%)

, RHHBY

Roche

$0.00

(0.00%)

04:55
12/15/18
12/15
04:55
12/15/18
04:55
Conference/Events
European Society for Medical Oncology (ESMO) to hold a conference »

ESMO Immuno-Oncology…

BMY

Bristol-Myers

$52.11

-1.54 (-2.87%)

RHHBY

Roche

$0.00

(0.00%)

CELG

Celgene

$68.20

-1.55 (-2.22%)

MRK

Merck

$76.50

-1.94 (-2.47%)

PFE

Pfizer

$43.84

-0.71 (-1.59%)

FLDM

Fluidigm

$7.79

-0.39 (-4.77%)

NEO

NeoGenomics

$13.25

-0.18 (-1.34%)

SGEN

Seattle Genetics

$60.46

-0.5 (-0.82%)

TKPYY

Takeda Pharmaceutical

$0.00

(0.00%)

IMV

IMV Inc

$5.65

-0.14 (-2.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 24

    Dec

  • 29

    Dec

  • 11

    Jan

  • 11

    Jan

  • 24

    Jan

  • 16

    Feb

  • 18

    Mar

  • 20

    May

  • 12

    Dec

  • 12

    Dec

TEVA

Teva

$18.46

-0.56 (-2.94%)

18:34
12/14/18
12/14
18:34
12/14/18
18:34
Hot Stocks
Teva, Celltrion announce FDA approval of HERZUMA »

Celltrion and Teva…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PVG

Pretium Resources

$7.43

(0.00%)

18:11
12/14/18
12/14
18:11
12/14/18
18:11
Hot Stocks
Pretium Resources: Brucejack approved for production hike to 3,800 tonnes/day »

Pretium Resources is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCAU

Fiat Chrysler

$15.47

-0.2 (-1.28%)

17:52
12/14/18
12/14
17:52
12/14/18
17:52
Periodicals
FCA says four U.S. plants to have down-time in January, Detroit News says »

Fiat Chrysler said that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNOA

Sonoma Pharmaceuticals

$0.75

-0.0342 (-4.36%)

, CCNI

Command Center

$4.00

-0.075 (-1.84%)

17:43
12/14/18
12/14
17:43
12/14/18
17:43
Hot Stocks
Sonoma Pharmaceuticals CEO Jim Schutz resigns, Frederick Sandford succeeds »

Sonoma Pharmaceuticals…

SNOA

Sonoma Pharmaceuticals

$0.75

-0.0342 (-4.36%)

CCNI

Command Center

$4.00

-0.075 (-1.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$62.09

-1.47 (-2.31%)

, XLU

Utilities SPDR

$56.81

-0.13 (-0.23%)

17:38
12/14/18
12/14
17:38
12/14/18
17:38
General news
Week ending ETF scorecard: Energy, Financials lead the decline »

S&P500 SECTORS:…

XLE

Energy Select Sector SPDR

$62.09

-1.47 (-2.31%)

XLU

Utilities SPDR

$56.81

-0.13 (-0.23%)

IYR

DJ US Real Estate Index Fund

$80.37

-0.14 (-0.17%)

XLP

Consumer Staples Sector SPDR

$54.51

-0.97 (-1.75%)

XLY

Consumer Discretionary Sector SPDR

$102.33

-1.75 (-1.68%)

XLB

S&P Select Materials SPDR

$51.37

-0.37 (-0.72%)

XLF

Financial Select Sector

$24.25

-0.24 (-0.98%)

XLV

Health Care Select Sector SPDR

$88.99

-3.05 (-3.31%)

XLK

Technology Select Sector SPDR

$64.58

-1.6 (-2.42%)

XLI

Industrial Select Sector SPDR

$67.06

-0.95 (-1.40%)

GLD

SPDR Gold Shares

$117.10

-0.44 (-0.37%)

SLV

iShares Silver Trust

$13.69

-0.175 (-1.26%)

USO

United States Oil Fund

$10.83

-0.38 (-3.39%)

UNG

United States Natural Gas Fund

$30.78

-2.64 (-7.90%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$83.17

-0.365 (-0.44%)

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$112.72

-0.125 (-0.11%)

TLT

iShares 20+ Year Treasury Bond Fund

$118.47

0.38 (0.32%)

IEF

iShares 7-10 Year Treasury Bond ETF

$102.57

0.19 (0.19%)

SHY

iShares 1-3 Year Treasury Bond

$83.31

0.055 (0.07%)

IWD

iShares Russell 1000 Value

$116.15

-1.71 (-1.45%)

IWF

iShares Russell 1000 Growth

$135.70

-2.96 (-2.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EEI

Ecology & Environment

$11.50

0.2 (1.77%)

17:35
12/14/18
12/14
17:35
12/14/18
17:35
Hot Stocks
Ecology & Environment receives Nasdaq noncompliance notice »

On December 13, 2018,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LBC

Luther Burbank

$8.96

-0.045 (-0.50%)

17:34
12/14/18
12/14
17:34
12/14/18
17:34
Hot Stocks
Luther Burbank announces systematic share repurchase plan »

Luther Burbank announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYND

MYnd Analytics

$1.33

0.01 (0.76%)

17:31
12/14/18
12/14
17:31
12/14/18
17:31
Syndicate
Breaking Syndicate news story on MYnd Analytics »

MYnd Analytics files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RLGT

Radiant Logistics

$4.76

-0.06 (-1.24%)

17:29
12/14/18
12/14
17:29
12/14/18
17:29
Syndicate
Breaking Syndicate news story on Radiant Logistics »

Radiant Logistics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KALV

KalVista

$22.62

-1.39 (-5.79%)

17:29
12/14/18
12/14
17:29
12/14/18
17:29
Syndicate
Breaking Syndicate news story on KalVista »

KalVista files $200M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$260.61

-4.8 (-1.81%)

17:25
12/14/18
12/14
17:25
12/14/18
17:25
Hot Stocks
POTUS names Mick Mulvaney acting WH chief of staff »

U.S. President Donald…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$260.61

-4.8 (-1.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RTN

Raytheon

$169.87

-2.585 (-1.50%)

17:20
12/14/18
12/14
17:20
12/14/18
17:20
Hot Stocks
Raytheon awarded $149.44M Navy contract for Standard Missile-2 Block IIIC »

Raytheon has been awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EOG

EOG Resources

$100.08

-2.73 (-2.66%)

17:15
12/14/18
12/14
17:15
12/14/18
17:15
Syndicate
Breaking Syndicate news story on EOG Resources »

EOG Resources files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FNCB

First National Community Bancorp, Inc.

$9.35

0.04 (0.43%)

17:14
12/14/18
12/14
17:14
12/14/18
17:14
Hot Stocks
First National Community Bancorp names R. Gregory Collins as new EVP »

FNCB Bancorp announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.